PRESS RELEASE published on 06/01/2026 at 11:54, 5 months 3 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL Sartorius Stedim Biotech SA déclare le nombre d'actions et de droits de vote au 31 mai 2026, conformément à la réglementation. Informations clés sur le capital social Déclaration Droits De Vote Capital Social Actions Sartorius Stedim Biotech SA
PRESS RELEASE published on 06/01/2026 at 11:54, 5 months 3 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares total number of shares and voting rights making up the issued capital in accordance with French regulatory requirements Voting Rights Capital Shares French Regulations Sartorius Stedim Biotech
BRIEF published on 05/05/2026 at 08:57, 5 months 30 days ago Sartorius Stedim Biotech : Déclaration sur le Capital Social Nombre D'actions Droits De Vote Capital Social Transparence Financière Sartorius Stedim
BRIEF published on 05/05/2026 at 08:57, 5 months 30 days ago Sartorius Stedim Biotech Declares Share and Voting Rights Details French Regulations Sartorius Stedim Biotech Issued Capital Shares And Voting Rights April 2026 Data
BRIEF published on 05/05/2026 at 08:57, 5 months 30 days ago Sartorius Stedim Biotech publie les détails relatifs aux actions et aux droits de vote Sartorius Stedim Biotech Capital Émis Actions Et Droits De Vote Réglementation Française Données D'avril 2026
BRIEF published on 05/05/2026 at 08:57, 5 months 30 days ago Sartorius Stedim Biotech: Statement on Share Capital Share Capital Voting Rights Financial Transparency Sartorius Stedim Number Of Shares
PRESS RELEASE published on 05/05/2026 at 08:53, 5 months 30 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL Sartorius Stedim Biotech S.A. announces total number of shares and voting rights as of April 30, 2026 Voting Rights Shares Sartorius Stedim Biotech Announcement April 30 2026
PRESS RELEASE published on 05/05/2026 at 08:53, 5 months 30 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech S.A. declares total shares and voting rights as of April 30, 2026 in Aubagne, France Voting Rights Shares Sartorius Stedim Biotech France Aubagne
PRESS RELEASE published on 05/05/2026 at 08:52, 5 months 30 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL Déclaration de Sartorius Stedim Biotech SA sur le nombre d'actions et de droits de vote. Date d'arrêté le 30 avril 2026 Déclaration Droits De Vote Capital Social Actions Sartorius Stedim Biotech
PRESS RELEASE published on 05/05/2026 at 08:52, 5 months 30 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights for its issued capital. Details provided according to regulatory requirements Voting Rights Shares Sartorius Stedim Biotech Regulatory Requirements Issued Capital
Published on 11/04/2026 at 23:10, 7 hours 59 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 8 hours 9 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 8 hours 54 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 9 hours 4 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 06:58, 11 minutes ago Aareal Bank leverages its operational strength to set the course for its strategic future
Published on 11/05/2026 at 06:58, 11 minutes ago AT&S reports record second-quarter results and fully confirms full-year guidance
Published on 11/05/2026 at 06:30, 39 minutes ago HENSOLDT increases adjusted EBITDA by 33% and refines guidance for 2026 upwards
Published on 11/05/2026 at 06:30, 39 minutes ago Formycon invites to conference call on 2026 nine-month results and announces participation in international investor conferences
Published on 11/05/2026 at 06:20, 49 minutes ago Zhejiang Showcases Its Cultural and Tourism Appeal in Hamburg at "Come for the Stories" Event
Published on 11/05/2026 at 07:00, 9 minutes ago Accélération confirmée au troisième trimestre 2026 Tous les métiers en croissance, chiffre d’affaires en progression de +6,5 %
Published on 11/05/2026 at 07:00, 9 minutes ago Eurazeo’s European asset management platform continues to gain momentum, driven by sustained international fundraising
Published on 11/05/2026 at 07:00, 9 minutes ago Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%
Published on 11/05/2026 at 07:00, 9 minutes ago Eurazeo confirme la dynamique de sa plateforme européenne de gestion d’actifs, portée par une collecte internationale soutenue
Published on 11/04/2026 at 18:00, 13 hours 9 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
